Discover key challenges in clinical trial design and learn how the right software can significantly boost the likelihood of ...

The Phase I expansion trial saw a 25.9% overall response rate (ORR) for endometrial cancer and 37.5% in platinum-resistant ...

OSF Cancer Institute is one of the chosen few participants in an exciting new cancer treatment trial program. The founder of ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

Natera (NTRA) announced the enrollment of the first patients in the SAGITTARIUS clinical trial. Sponsored by The AIRC ...

Creating contingency plans against geopolitical uncertainty was a key theme at the 2024 Outsourcing in Clinical Trials and ...

Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program, shares findings on ...

Marcus Evans is proud to announce the Evolution Summit 2025, an exclusive, invitation-only event that will unite leading clinical trial executives with innovative suppliers and solution providers in ...

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

On November 8, the Department of Labor (DOL) issued an opinion letter addressing an interesting question under the Family and ...

The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, whose ...